PolyTherics and Zealand Pharma to collaborate on pegylated peptide therapeutics
This article was originally published in Scrip
Executive Summary
PolyTherics is to contribute its pegylation expertise to improve the duration of action of peptide-based therapeutic candidates developed by Zealand Pharma in a new research collaboration.